This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Pharmabcine Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Nu Ri Kang: Innovator in Antibody Development
Introduction
Nu Ri Kang is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His innovative work has led to the creation of a patent that holds promise for medical advancements.
Latest Patents
Nu Ri Kang holds a patent for an "ANTI-TIE2 ANTIBODY AND USE THEREOF." This invention is crucial in the ongoing research and development of therapeutic options targeting specific diseases. The patent showcases his expertise and commitment to advancing medical science.
Career Highlights
Nu Ri Kang is currently employed at Pharmabcine Inc., a company dedicated to developing innovative therapies. His role at Pharmabcine allows him to work on cutting-edge projects that aim to improve patient outcomes. With 1 patent to his name, he has established himself as a valuable asset in the biotechnology sector.
Collaborations
Nu Ri Kang collaborates with talented colleagues, including Eun-Ah Lee and Beom Yong Park. Together, they contribute to the research and development efforts at Pharmabcine Inc., fostering a collaborative environment that encourages innovation.
Conclusion
Nu Ri Kang's work in antibody development exemplifies the spirit of innovation in biotechnology. His contributions are paving the way for future advancements in medical treatments.